{ "id": "synthroid", "recordTier": "source_traceable_archive", "editorial": { "reviewedAt": "2026-08-21", "status": "published_traceable_archive" }, "names": { "brand": "Synthroid", "generic": "左甲状腺素", "aliases": [ "levothyroxine" ], "marketBrandNames": [], "mainlandChinaTradeNameCue": null }, "identity": { "therapeuticArea": "代谢", "sourceArchiveMarket": "美国 SYNTHROID 公开标签（DailyMed 页面 2024-02-20 更新；处方信息 2024-02 修订）", "dosageFormClass": "左甲状腺素钠口服片：25、50、75、88、100、112、125、137、150、175、200、300 mcg（本档案分别展示 12 个美国标签包装面板）", "dosageFormClassCode": "oral_solid", "route": "口服", "routeCode": "oral", "historicalApprovalEntry": "2002（DailyMed 2024-02 美国公开标签所列 Initial U.S. Approval）", "archiveSponsorText": "AbbVie Inc. / DailyMed（NLM）美国公开标签" }, "matchPolicy": { "contract": "reviewed_name_and_exclusion_cues_v1", "exactMatchNames": [], "excludedProductCues": [], "exclusionPrecedence": "before_name_candidate" }, "productPresentations": [ { "id": "us-synthroid-levothyroxine-tablet-25mcg-0074434119", "marketCode": "US", "labelVersion": { "zh": "DailyMed 页面 2024-02-20 更新；处方信息 2024-02 修订", "en": "DailyMed updated 20 Feb 2024; prescribing information revised Feb 2024" }, "dosageForm": { "zh": "左甲状腺素钠口服片", "en": "levothyroxine sodium oral tablet" }, "route": { "zh": "口服（仅作标签产品身份字段）", "en": "oral (label product-identity field only)" }, "routeCodes": [ "oral" ], "productCode": "NDC 0074-4341-19", "pouchCode": null, "applicationNumber": null, "presentationRole": null, "primaryStrengthBasisCode": "per_tablet", "primaryDisplay": { "zh": "每片 25 mcg（0.025 mg）；1000 片瓶装", "en": "25 mcg (0.025 mg) per tablet; 1000-tablet bottle" }, "imageUrl": "https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc&name=synthroid-spl-06.jpg", "visualStatus": "exact_public_label_package_image", "labeledQuantities": [ { "ingredient": { "zh": "左甲状腺素钠", "en": "levothyroxine sodium" }, "value": 25, "unit": "mcg", "basisCode": "per_tablet", "basisLabel": { "zh": "每片标签标示量；不是个人服用片数、调量或换算指令", "en": "labelled amount per tablet; not an individual tablet count, adjustment or conversion instruction" } } ], "concentration": null, "container": { "typeCode": "bottle", "typeLabel": { "zh": "原瓶", "en": "bottle" }, "fill": null, "countPerPackage": 1000, "countUnit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "deliveryDevice": null, "compatibleReusableDevice": null, "listingStatus": { "reviewedAt": "2026-08-21", "currentLabelDisplayed": true, "ndcDirectoryListed": true, "marketAvailability": "not_established", "marketingStartDate": null, "marketingEndDate": null, "purpleBookPresentationStatus": null, "statusConflictRequiresManualReview": false }, "package": { "count": 1000, "unit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "physicalClues": { "color": { "zh": "橙色", "en": "orange" }, "shape": { "zh": "圆形片", "en": "round tablet" }, "imprint": "SYNTHROID / 25", "scoreStatus": null, "patchAreaCm2": null }, "comparisonNotice": null, "source": { "id": "src_9fe75faad23655ce", "label": "DailyMed（NLM）：SYNTHROID 左甲状腺素钠美国公开标签（AbbVie；2024-02 修订）", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "publication_status_unresolved", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "scope": "package_and_label_identity_only_not_personal_dosing_or_conversion" }, { "id": "us-synthroid-levothyroxine-tablet-50mcg-0074455211", "marketCode": "US", "labelVersion": { "zh": "DailyMed 页面 2024-02-20 更新；处方信息 2024-02 修订", "en": "DailyMed updated 20 Feb 2024; prescribing information revised Feb 2024" }, "dosageForm": { "zh": "左甲状腺素钠口服片", "en": "levothyroxine sodium oral tablet" }, "route": { "zh": "口服（仅作标签产品身份字段）", "en": "oral (label product-identity field only)" }, "routeCodes": [ "oral" ], "productCode": "NDC 0074-4552-11", "pouchCode": null, "applicationNumber": null, "presentationRole": null, "primaryStrengthBasisCode": "per_tablet", "primaryDisplay": { "zh": "每片 50 mcg（0.05 mg）；100 片纸盒（单位剂量包装）", "en": "50 mcg (0.05 mg) per tablet; 100-tablet carton (unit-dose package)" }, "imageUrl": "https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc&name=synthroid-spl-02.jpg", "visualStatus": "exact_public_label_package_image", "labeledQuantities": [ { "ingredient": { "zh": "左甲状腺素钠", "en": "levothyroxine sodium" }, "value": 50, "unit": "mcg", "basisCode": "per_tablet", "basisLabel": { "zh": "每片标签标示量；不是个人服用片数、调量或换算指令", "en": "labelled amount per tablet; not an individual tablet count, adjustment or conversion instruction" } } ], "concentration": null, "container": { "typeCode": "unit_dose_carton", "typeLabel": { "zh": "单位剂量纸盒", "en": "unit-dose carton" }, "fill": null, "countPerPackage": 100, "countUnit": { "zh": "片/盒", "en": "tablets per carton" } }, "deliveryDevice": null, "compatibleReusableDevice": null, "listingStatus": { "reviewedAt": "2026-08-21", "currentLabelDisplayed": true, "ndcDirectoryListed": true, "marketAvailability": "not_established", "marketingStartDate": null, "marketingEndDate": null, "purpleBookPresentationStatus": null, "statusConflictRequiresManualReview": false }, "package": { "count": 100, "unit": { "zh": "片/单位剂量纸盒", "en": "tablets per unit-dose carton" } }, "physicalClues": { "color": { "zh": "白色", "en": "white" }, "shape": { "zh": "圆形片", "en": "round tablet" }, "imprint": "SYNTHROID / 50", "scoreStatus": null, "patchAreaCm2": null }, "comparisonNotice": null, "source": { "id": "src_9fe75faad23655ce", "label": "DailyMed（NLM）：SYNTHROID 左甲状腺素钠美国公开标签（AbbVie；2024-02 修订）", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "publication_status_unresolved", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "scope": "package_and_label_identity_only_not_personal_dosing_or_conversion" }, { "id": "us-synthroid-levothyroxine-tablet-75mcg-0074518219", "marketCode": "US", "labelVersion": { "zh": "DailyMed 页面 2024-02-20 更新；处方信息 2024-02 修订", "en": "DailyMed updated 20 Feb 2024; prescribing information revised Feb 2024" }, "dosageForm": { "zh": "左甲状腺素钠口服片", "en": "levothyroxine sodium oral tablet" }, "route": { "zh": "口服（仅作标签产品身份字段）", "en": "oral (label product-identity field only)" }, "routeCodes": [ "oral" ], "productCode": "NDC 0074-5182-19", "pouchCode": null, "applicationNumber": null, "presentationRole": null, "primaryStrengthBasisCode": "per_tablet", "primaryDisplay": { "zh": "每片 75 mcg（0.075 mg）；1000 片瓶装", "en": "75 mcg (0.075 mg) per tablet; 1000-tablet bottle" }, "imageUrl": "https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc&name=synthroid-spl-07.jpg", "visualStatus": "exact_public_label_package_image", "labeledQuantities": [ { "ingredient": { "zh": "左甲状腺素钠", "en": "levothyroxine sodium" }, "value": 75, "unit": "mcg", "basisCode": "per_tablet", "basisLabel": { "zh": "每片标签标示量；不是个人服用片数、调量或换算指令", "en": "labelled amount per tablet; not an individual tablet count, adjustment or conversion instruction" } } ], "concentration": null, "container": { "typeCode": "bottle", "typeLabel": { "zh": "原瓶", "en": "bottle" }, "fill": null, "countPerPackage": 1000, "countUnit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "deliveryDevice": null, "compatibleReusableDevice": null, "listingStatus": { "reviewedAt": "2026-08-21", "currentLabelDisplayed": true, "ndcDirectoryListed": true, "marketAvailability": "not_established", "marketingStartDate": null, "marketingEndDate": null, "purpleBookPresentationStatus": null, "statusConflictRequiresManualReview": false }, "package": { "count": 1000, "unit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "physicalClues": { "color": { "zh": "紫色", "en": "violet" }, "shape": { "zh": "圆形片", "en": "round tablet" }, "imprint": "SYNTHROID / 75", "scoreStatus": null, "patchAreaCm2": null }, "comparisonNotice": null, "source": { "id": "src_9fe75faad23655ce", "label": "DailyMed（NLM）：SYNTHROID 左甲状腺素钠美国公开标签（AbbVie；2024-02 修订）", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "publication_status_unresolved", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "scope": "package_and_label_identity_only_not_personal_dosing_or_conversion" }, { "id": "us-synthroid-levothyroxine-tablet-88mcg-0074659490", "marketCode": "US", "labelVersion": { "zh": "DailyMed 页面 2024-02-20 更新；处方信息 2024-02 修订", "en": "DailyMed updated 20 Feb 2024; prescribing information revised Feb 2024" }, "dosageForm": { "zh": "左甲状腺素钠口服片", "en": "levothyroxine sodium oral tablet" }, "route": { "zh": "口服（仅作标签产品身份字段）", "en": "oral (label product-identity field only)" }, "routeCodes": [ "oral" ], "productCode": "NDC 0074-6594-90", "pouchCode": null, "applicationNumber": null, "presentationRole": null, "primaryStrengthBasisCode": "per_tablet", "primaryDisplay": { "zh": "每片 88 mcg（0.088 mg）；90 片瓶装", "en": "88 mcg (0.088 mg) per tablet; 90-tablet bottle" }, "imageUrl": "https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc&name=synthroid-spl-08.jpg", "visualStatus": "exact_public_label_package_image", "labeledQuantities": [ { "ingredient": { "zh": "左甲状腺素钠", "en": "levothyroxine sodium" }, "value": 88, "unit": "mcg", "basisCode": "per_tablet", "basisLabel": { "zh": "每片标签标示量；不是个人服用片数、调量或换算指令", "en": "labelled amount per tablet; not an individual tablet count, adjustment or conversion instruction" } } ], "concentration": null, "container": { "typeCode": "bottle", "typeLabel": { "zh": "原瓶", "en": "bottle" }, "fill": null, "countPerPackage": 90, "countUnit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "deliveryDevice": null, "compatibleReusableDevice": null, "listingStatus": { "reviewedAt": "2026-08-21", "currentLabelDisplayed": true, "ndcDirectoryListed": true, "marketAvailability": "not_established", "marketingStartDate": null, "marketingEndDate": null, "purpleBookPresentationStatus": null, "statusConflictRequiresManualReview": false }, "package": { "count": 90, "unit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "physicalClues": { "color": { "zh": "橄榄色", "en": "olive" }, "shape": { "zh": "圆形片", "en": "round tablet" }, "imprint": "SYNTHROID / 88", "scoreStatus": null, "patchAreaCm2": null }, "comparisonNotice": null, "source": { "id": "src_9fe75faad23655ce", "label": "DailyMed（NLM）：SYNTHROID 左甲状腺素钠美国公开标签（AbbVie；2024-02 修订）", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "publication_status_unresolved", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "scope": "package_and_label_identity_only_not_personal_dosing_or_conversion" }, { "id": "us-synthroid-levothyroxine-tablet-100mcg-0074662411", "marketCode": "US", "labelVersion": { "zh": "DailyMed 页面 2024-02-20 更新；处方信息 2024-02 修订", "en": "DailyMed updated 20 Feb 2024; prescribing information revised Feb 2024" }, "dosageForm": { "zh": "左甲状腺素钠口服片", "en": "levothyroxine sodium oral tablet" }, "route": { "zh": "口服（仅作标签产品身份字段）", "en": "oral (label product-identity field only)" }, "routeCodes": [ "oral" ], "productCode": "NDC 0074-6624-11", "pouchCode": null, "applicationNumber": null, "presentationRole": null, "primaryStrengthBasisCode": "per_tablet", "primaryDisplay": { "zh": "每片 100 mcg（0.1 mg）；100 片纸盒（单位剂量包装）", "en": "100 mcg (0.1 mg) per tablet; 100-tablet carton (unit-dose package)" }, "imageUrl": "https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc&name=synthroid-spl-03.jpg", "visualStatus": "exact_public_label_package_image", "labeledQuantities": [ { "ingredient": { "zh": "左甲状腺素钠", "en": "levothyroxine sodium" }, "value": 100, "unit": "mcg", "basisCode": "per_tablet", "basisLabel": { "zh": "每片标签标示量；不是个人服用片数、调量或换算指令", "en": "labelled amount per tablet; not an individual tablet count, adjustment or conversion instruction" } } ], "concentration": null, "container": { "typeCode": "unit_dose_carton", "typeLabel": { "zh": "单位剂量纸盒", "en": "unit-dose carton" }, "fill": null, "countPerPackage": 100, "countUnit": { "zh": "片/盒", "en": "tablets per carton" } }, "deliveryDevice": null, "compatibleReusableDevice": null, "listingStatus": { "reviewedAt": "2026-08-21", "currentLabelDisplayed": true, "ndcDirectoryListed": true, "marketAvailability": "not_established", "marketingStartDate": null, "marketingEndDate": null, "purpleBookPresentationStatus": null, "statusConflictRequiresManualReview": false }, "package": { "count": 100, "unit": { "zh": "片/单位剂量纸盒", "en": "tablets per unit-dose carton" } }, "physicalClues": { "color": { "zh": "黄色", "en": "yellow" }, "shape": { "zh": "圆形片", "en": "round tablet" }, "imprint": "SYNTHROID / 100", "scoreStatus": null, "patchAreaCm2": null }, "comparisonNotice": null, "source": { "id": "src_9fe75faad23655ce", "label": "DailyMed（NLM）：SYNTHROID 左甲状腺素钠美国公开标签（AbbVie；2024-02 修订）", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "publication_status_unresolved", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "scope": "package_and_label_identity_only_not_personal_dosing_or_conversion" }, { "id": "us-synthroid-levothyroxine-tablet-112mcg-0074929619", "marketCode": "US", "labelVersion": { "zh": "DailyMed 页面 2024-02-20 更新；处方信息 2024-02 修订", "en": "DailyMed updated 20 Feb 2024; prescribing information revised Feb 2024" }, "dosageForm": { "zh": "左甲状腺素钠口服片", "en": "levothyroxine sodium oral tablet" }, "route": { "zh": "口服（仅作标签产品身份字段）", "en": "oral (label product-identity field only)" }, "routeCodes": [ "oral" ], "productCode": "NDC 0074-9296-19", "pouchCode": null, "applicationNumber": null, "presentationRole": null, "primaryStrengthBasisCode": "per_tablet", "primaryDisplay": { "zh": "每片 112 mcg（0.112 mg）；1000 片瓶装", "en": "112 mcg (0.112 mg) per tablet; 1000-tablet bottle" }, "imageUrl": "https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc&name=synthroid-spl-0d.jpg", "visualStatus": "exact_public_label_package_image", "labeledQuantities": [ { "ingredient": { "zh": "左甲状腺素钠", "en": "levothyroxine sodium" }, "value": 112, "unit": "mcg", "basisCode": "per_tablet", "basisLabel": { "zh": "每片标签标示量；不是个人服用片数、调量或换算指令", "en": "labelled amount per tablet; not an individual tablet count, adjustment or conversion instruction" } } ], "concentration": null, "container": { "typeCode": "bottle", "typeLabel": { "zh": "原瓶", "en": "bottle" }, "fill": null, "countPerPackage": 1000, "countUnit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "deliveryDevice": null, "compatibleReusableDevice": null, "listingStatus": { "reviewedAt": "2026-08-21", "currentLabelDisplayed": true, "ndcDirectoryListed": true, "marketAvailability": "not_established", "marketingStartDate": null, "marketingEndDate": null, "purpleBookPresentationStatus": null, "statusConflictRequiresManualReview": false }, "package": { "count": 1000, "unit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "physicalClues": { "color": { "zh": "玫瑰色", "en": "rose" }, "shape": { "zh": "圆形片", "en": "round tablet" }, "imprint": "SYNTHROID / 112", "scoreStatus": null, "patchAreaCm2": null }, "comparisonNotice": null, "source": { "id": "src_9fe75faad23655ce", "label": "DailyMed（NLM）：SYNTHROID 左甲状腺素钠美国公开标签（AbbVie；2024-02 修订）", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "publication_status_unresolved", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "scope": "package_and_label_identity_only_not_personal_dosing_or_conversion" }, { "id": "us-synthroid-levothyroxine-tablet-125mcg-0074706819", "marketCode": "US", "labelVersion": { "zh": "DailyMed 页面 2024-02-20 更新；处方信息 2024-02 修订", "en": "DailyMed updated 20 Feb 2024; prescribing information revised Feb 2024" }, "dosageForm": { "zh": "左甲状腺素钠口服片", "en": "levothyroxine sodium oral tablet" }, "route": { "zh": "口服（仅作标签产品身份字段）", "en": "oral (label product-identity field only)" }, "routeCodes": [ "oral" ], "productCode": "NDC 0074-7068-19", "pouchCode": null, "applicationNumber": null, "presentationRole": null, "primaryStrengthBasisCode": "per_tablet", "primaryDisplay": { "zh": "每片 125 mcg（0.125 mg）；1000 片瓶装", "en": "125 mcg (0.125 mg) per tablet; 1000-tablet bottle" }, "imageUrl": "https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc&name=synthroid-spl-09.jpg", "visualStatus": "exact_public_label_package_image", "labeledQuantities": [ { "ingredient": { "zh": "左甲状腺素钠", "en": "levothyroxine sodium" }, "value": 125, "unit": "mcg", "basisCode": "per_tablet", "basisLabel": { "zh": "每片标签标示量；不是个人服用片数、调量或换算指令", "en": "labelled amount per tablet; not an individual tablet count, adjustment or conversion instruction" } } ], "concentration": null, "container": { "typeCode": "bottle", "typeLabel": { "zh": "原瓶", "en": "bottle" }, "fill": null, "countPerPackage": 1000, "countUnit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "deliveryDevice": null, "compatibleReusableDevice": null, "listingStatus": { "reviewedAt": "2026-08-21", "currentLabelDisplayed": true, "ndcDirectoryListed": true, "marketAvailability": "not_established", "marketingStartDate": null, "marketingEndDate": null, "purpleBookPresentationStatus": null, "statusConflictRequiresManualReview": false }, "package": { "count": 1000, "unit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "physicalClues": { "color": { "zh": "棕色", "en": "brown" }, "shape": { "zh": "圆形片", "en": "round tablet" }, "imprint": "SYNTHROID / 125", "scoreStatus": null, "patchAreaCm2": null }, "comparisonNotice": null, "source": { "id": "src_9fe75faad23655ce", "label": "DailyMed（NLM）：SYNTHROID 左甲状腺素钠美国公开标签（AbbVie；2024-02 修订）", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "publication_status_unresolved", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "scope": "package_and_label_identity_only_not_personal_dosing_or_conversion" }, { "id": "us-synthroid-levothyroxine-tablet-137mcg-0074372790", "marketCode": "US", "labelVersion": { "zh": "DailyMed 页面 2024-02-20 更新；处方信息 2024-02 修订", "en": "DailyMed updated 20 Feb 2024; prescribing information revised Feb 2024" }, "dosageForm": { "zh": "左甲状腺素钠口服片", "en": "levothyroxine sodium oral tablet" }, "route": { "zh": "口服（仅作标签产品身份字段）", "en": "oral (label product-identity field only)" }, "routeCodes": [ "oral" ], "productCode": "NDC 0074-3727-90", "pouchCode": null, "applicationNumber": null, "presentationRole": null, "primaryStrengthBasisCode": "per_tablet", "primaryDisplay": { "zh": "每片 137 mcg（0.137 mg）；90 片瓶装", "en": "137 mcg (0.137 mg) per tablet; 90-tablet bottle" }, "imageUrl": "https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc&name=synthroid-spl-05.jpg", "visualStatus": "exact_public_label_package_image", "labeledQuantities": [ { "ingredient": { "zh": "左甲状腺素钠", "en": "levothyroxine sodium" }, "value": 137, "unit": "mcg", "basisCode": "per_tablet", "basisLabel": { "zh": "每片标签标示量；不是个人服用片数、调量或换算指令", "en": "labelled amount per tablet; not an individual tablet count, adjustment or conversion instruction" } } ], "concentration": null, "container": { "typeCode": "bottle", "typeLabel": { "zh": "原瓶", "en": "bottle" }, "fill": null, "countPerPackage": 90, "countUnit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "deliveryDevice": null, "compatibleReusableDevice": null, "listingStatus": { "reviewedAt": "2026-08-21", "currentLabelDisplayed": true, "ndcDirectoryListed": true, "marketAvailability": "not_established", "marketingStartDate": null, "marketingEndDate": null, "purpleBookPresentationStatus": null, "statusConflictRequiresManualReview": false }, "package": { "count": 90, "unit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "physicalClues": { "color": { "zh": "青绿色", "en": "turquoise" }, "shape": { "zh": "圆形片", "en": "round tablet" }, "imprint": "SYNTHROID / 137", "scoreStatus": null, "patchAreaCm2": null }, "comparisonNotice": null, "source": { "id": "src_9fe75faad23655ce", "label": "DailyMed（NLM）：SYNTHROID 左甲状腺素钠美国公开标签（AbbVie；2024-02 修订）", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "publication_status_unresolved", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "scope": "package_and_label_identity_only_not_personal_dosing_or_conversion" }, { "id": "us-synthroid-levothyroxine-tablet-150mcg-0074706990", "marketCode": "US", "labelVersion": { "zh": "DailyMed 页面 2024-02-20 更新；处方信息 2024-02 修订", "en": "DailyMed updated 20 Feb 2024; prescribing information revised Feb 2024" }, "dosageForm": { "zh": "左甲状腺素钠口服片", "en": "levothyroxine sodium oral tablet" }, "route": { "zh": "口服（仅作标签产品身份字段）", "en": "oral (label product-identity field only)" }, "routeCodes": [ "oral" ], "productCode": "NDC 0074-7069-90", "pouchCode": null, "applicationNumber": null, "presentationRole": null, "primaryStrengthBasisCode": "per_tablet", "primaryDisplay": { "zh": "每片 150 mcg（0.15 mg）；90 片瓶装", "en": "150 mcg (0.15 mg) per tablet; 90-tablet bottle" }, "imageUrl": "https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc&name=synthroid-spl-0a.jpg", "visualStatus": "exact_public_label_package_image", "labeledQuantities": [ { "ingredient": { "zh": "左甲状腺素钠", "en": "levothyroxine sodium" }, "value": 150, "unit": "mcg", "basisCode": "per_tablet", "basisLabel": { "zh": "每片标签标示量；不是个人服用片数、调量或换算指令", "en": "labelled amount per tablet; not an individual tablet count, adjustment or conversion instruction" } } ], "concentration": null, "container": { "typeCode": "bottle", "typeLabel": { "zh": "原瓶", "en": "bottle" }, "fill": null, "countPerPackage": 90, "countUnit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "deliveryDevice": null, "compatibleReusableDevice": null, "listingStatus": { "reviewedAt": "2026-08-21", "currentLabelDisplayed": true, "ndcDirectoryListed": true, "marketAvailability": "not_established", "marketingStartDate": null, "marketingEndDate": null, "purpleBookPresentationStatus": null, "statusConflictRequiresManualReview": false }, "package": { "count": 90, "unit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "physicalClues": { "color": { "zh": "蓝色", "en": "blue" }, "shape": { "zh": "圆形片", "en": "round tablet" }, "imprint": "SYNTHROID / 150", "scoreStatus": null, "patchAreaCm2": null }, "comparisonNotice": null, "source": { "id": "src_9fe75faad23655ce", "label": "DailyMed（NLM）：SYNTHROID 左甲状腺素钠美国公开标签（AbbVie；2024-02 修订）", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "publication_status_unresolved", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "scope": "package_and_label_identity_only_not_personal_dosing_or_conversion" }, { "id": "us-synthroid-levothyroxine-tablet-175mcg-0074707019", "marketCode": "US", "labelVersion": { "zh": "DailyMed 页面 2024-02-20 更新；处方信息 2024-02 修订", "en": "DailyMed updated 20 Feb 2024; prescribing information revised Feb 2024" }, "dosageForm": { "zh": "左甲状腺素钠口服片", "en": "levothyroxine sodium oral tablet" }, "route": { "zh": "口服（仅作标签产品身份字段）", "en": "oral (label product-identity field only)" }, "routeCodes": [ "oral" ], "productCode": "NDC 0074-7070-19", "pouchCode": null, "applicationNumber": null, "presentationRole": null, "primaryStrengthBasisCode": "per_tablet", "primaryDisplay": { "zh": "每片 175 mcg（0.175 mg）；1000 片瓶装", "en": "175 mcg (0.175 mg) per tablet; 1000-tablet bottle" }, "imageUrl": "https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc&name=synthroid-spl-0b.jpg", "visualStatus": "exact_public_label_package_image", "labeledQuantities": [ { "ingredient": { "zh": "左甲状腺素钠", "en": "levothyroxine sodium" }, "value": 175, "unit": "mcg", "basisCode": "per_tablet", "basisLabel": { "zh": "每片标签标示量；不是个人服用片数、调量或换算指令", "en": "labelled amount per tablet; not an individual tablet count, adjustment or conversion instruction" } } ], "concentration": null, "container": { "typeCode": "bottle", "typeLabel": { "zh": "原瓶", "en": "bottle" }, "fill": null, "countPerPackage": 1000, "countUnit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "deliveryDevice": null, "compatibleReusableDevice": null, "listingStatus": { "reviewedAt": "2026-08-21", "currentLabelDisplayed": true, "ndcDirectoryListed": true, "marketAvailability": "not_established", "marketingStartDate": null, "marketingEndDate": null, "purpleBookPresentationStatus": null, "statusConflictRequiresManualReview": false }, "package": { "count": 1000, "unit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "physicalClues": { "color": { "zh": "淡紫色", "en": "lilac" }, "shape": { "zh": "圆形片", "en": "round tablet" }, "imprint": "SYNTHROID / 175", "scoreStatus": null, "patchAreaCm2": null }, "comparisonNotice": null, "source": { "id": "src_9fe75faad23655ce", "label": "DailyMed（NLM）：SYNTHROID 左甲状腺素钠美国公开标签（AbbVie；2024-02 修订）", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "publication_status_unresolved", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "scope": "package_and_label_identity_only_not_personal_dosing_or_conversion" }, { "id": "us-synthroid-levothyroxine-tablet-200mcg-0074714811", "marketCode": "US", "labelVersion": { "zh": "DailyMed 页面 2024-02-20 更新；处方信息 2024-02 修订", "en": "DailyMed updated 20 Feb 2024; prescribing information revised Feb 2024" }, "dosageForm": { "zh": "左甲状腺素钠口服片", "en": "levothyroxine sodium oral tablet" }, "route": { "zh": "口服（仅作标签产品身份字段）", "en": "oral (label product-identity field only)" }, "routeCodes": [ "oral" ], "productCode": "NDC 0074-7148-11", "pouchCode": null, "applicationNumber": null, "presentationRole": null, "primaryStrengthBasisCode": "per_tablet", "primaryDisplay": { "zh": "每片 200 mcg（0.2 mg）；100 片纸盒（单位剂量包装）", "en": "200 mcg (0.2 mg) per tablet; 100-tablet carton (unit-dose package)" }, "imageUrl": "https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc&name=synthroid-spl-04.jpg", "visualStatus": "exact_public_label_package_image", "labeledQuantities": [ { "ingredient": { "zh": "左甲状腺素钠", "en": "levothyroxine sodium" }, "value": 200, "unit": "mcg", "basisCode": "per_tablet", "basisLabel": { "zh": "每片标签标示量；不是个人服用片数、调量或换算指令", "en": "labelled amount per tablet; not an individual tablet count, adjustment or conversion instruction" } } ], "concentration": null, "container": { "typeCode": "unit_dose_carton", "typeLabel": { "zh": "单位剂量纸盒", "en": "unit-dose carton" }, "fill": null, "countPerPackage": 100, "countUnit": { "zh": "片/盒", "en": "tablets per carton" } }, "deliveryDevice": null, "compatibleReusableDevice": null, "listingStatus": { "reviewedAt": "2026-08-21", "currentLabelDisplayed": true, "ndcDirectoryListed": true, "marketAvailability": "not_established", "marketingStartDate": null, "marketingEndDate": null, "purpleBookPresentationStatus": null, "statusConflictRequiresManualReview": false }, "package": { "count": 100, "unit": { "zh": "片/单位剂量纸盒", "en": "tablets per unit-dose carton" } }, "physicalClues": { "color": { "zh": "粉色", "en": "pink" }, "shape": { "zh": "圆形片", "en": "round tablet" }, "imprint": "SYNTHROID / 200", "scoreStatus": null, "patchAreaCm2": null }, "comparisonNotice": null, "source": { "id": "src_9fe75faad23655ce", "label": "DailyMed（NLM）：SYNTHROID 左甲状腺素钠美国公开标签（AbbVie；2024-02 修订）", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "publication_status_unresolved", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "scope": "package_and_label_identity_only_not_personal_dosing_or_conversion" }, { "id": "us-synthroid-levothyroxine-tablet-300mcg-0074714990", "marketCode": "US", "labelVersion": { "zh": "DailyMed 页面 2024-02-20 更新；处方信息 2024-02 修订", "en": "DailyMed updated 20 Feb 2024; prescribing information revised Feb 2024" }, "dosageForm": { "zh": "左甲状腺素钠口服片", "en": "levothyroxine sodium oral tablet" }, "route": { "zh": "口服（仅作标签产品身份字段）", "en": "oral (label product-identity field only)" }, "routeCodes": [ "oral" ], "productCode": "NDC 0074-7149-90", "pouchCode": null, "applicationNumber": null, "presentationRole": null, "primaryStrengthBasisCode": "per_tablet", "primaryDisplay": { "zh": "每片 300 mcg（0.3 mg）；90 片瓶装", "en": "300 mcg (0.3 mg) per tablet; 90-tablet bottle" }, "imageUrl": "https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc&name=synthroid-spl-0c.jpg", "visualStatus": "exact_public_label_package_image", "labeledQuantities": [ { "ingredient": { "zh": "左甲状腺素钠", "en": "levothyroxine sodium" }, "value": 300, "unit": "mcg", "basisCode": "per_tablet", "basisLabel": { "zh": "每片标签标示量；不是个人服用片数、调量或换算指令", "en": "labelled amount per tablet; not an individual tablet count, adjustment or conversion instruction" } } ], "concentration": null, "container": { "typeCode": "bottle", "typeLabel": { "zh": "原瓶", "en": "bottle" }, "fill": null, "countPerPackage": 90, "countUnit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "deliveryDevice": null, "compatibleReusableDevice": null, "listingStatus": { "reviewedAt": "2026-08-21", "currentLabelDisplayed": true, "ndcDirectoryListed": true, "marketAvailability": "not_established", "marketingStartDate": null, "marketingEndDate": null, "purpleBookPresentationStatus": null, "statusConflictRequiresManualReview": false }, "package": { "count": 90, "unit": { "zh": "片/瓶", "en": "tablets per bottle" } }, "physicalClues": { "color": { "zh": "绿色", "en": "green" }, "shape": { "zh": "圆形片", "en": "round tablet" }, "imprint": "SYNTHROID / 300", "scoreStatus": null, "patchAreaCm2": null }, "comparisonNotice": null, "source": { "id": "src_9fe75faad23655ce", "label": "DailyMed（NLM）：SYNTHROID 左甲状腺素钠美国公开标签（AbbVie；2024-02 修订）", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "publication_status_unresolved", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "scope": "package_and_label_identity_only_not_personal_dosing_or_conversion" } ], "comparisonPresentations": [], "appearanceReferences": [], "visualReference": { "presentationId": "us-synthroid-levothyroxine-tablet-50mcg-0074455211", "status": "historical_public_label_image_not_product_authentication", "imageUrl": "https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=synthroid-spl-02.jpg&setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc&type=img", "alt": "SYNTHROID 50 mcg（0.05 mg）左甲状腺素钠片、NDC 0074-4552-11、100 片单位剂量纸盒在美国 DailyMed 公开标签中的展开图", "archiveMarket": "美国", "labelVersion": "2024-02", "presentation": "SYNTHROID 50 mcg（0.05 mg）、NDC 0074-4552-11、100 片单位剂量纸盒展开图（DailyMed 2024-02 美国公开标签）。", "notice": "此图只对应美国 DailyMed 公开标签中的 SYNTHROID 50 mcg（0.05 mg）、NDC 0074-4552-11、100 片单位剂量纸盒。它只帮助核对品牌、通用名、每片标示量、包装数量与来源；不用于鉴定真伪，也不证明其他强度、其他包装、其他市场标签、原研身份、目标市场批准、可售资格，或任何个人该吃几片、能否对半、调量或换算。", "source": { "id": "src_9fe75faad23655ce", "label": "DailyMed（NLM）：SYNTHROID 左甲状腺素钠美国公开标签（AbbVie；2024-02 修订）", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "publication_status_unresolved", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" } }, "visualCoverageNote": null, "labelReading": { "coverage": "drug_specific_source_review", "title": { "zh": "SYNTHROID 说明书放大阅读：mcg 与 mg 相差一千倍，不能凭感觉换算", "en": "SYNTHROID label reading: mcg and mg differ by a thousand-fold and are not converted by feeling" }, "summary": { "zh": "本模块以 FDA 2020 美国标签为阅读入口，帮助核对 SYNTHROID、左甲状腺素、每片标示的微克（mcg）强度和目标市场；它不提供个人片数、补服、调量或与另一种甲状腺激素产品转换的方案。", "en": "This module uses the 2020 U.S. FDA label as a reading entry point. It helps check SYNTHROID, levothyroxine, the microgram (mcg) strength per tablet and target market; it does not provide an individual tablet count, make-up use, adjustment or conversion to another thyroid-hormone product." }, "checks": [ { "zh": "先核对 SYNTHROID、左甲状腺素、每片标示的 mcg、实际包装和目标市场。mcg（微克）与 mg（毫克）是不同单位，1 mg 等于 1000 mcg；单位相近的写法不能用来凭经验换片数。", "en": "Check SYNTHROID, levothyroxine, the mcg strength per tablet, actual package and target market first. mcg (micrograms) and mg (milligrams) are different units: 1 mg equals 1,000 mcg. Similar-looking units must not be used to convert tablet count by experience." }, { "zh": "不同颜色、不同 mcg 强度、不同品牌或其他市场包装都属于不同产品身份线索。即使都写“甲状腺素”，也不表示可以把两种片剂自行等量替换、掰半拼凑或交替服用。", "en": "Different colours, mcg strengths, brands or market packs are different product-identity clues. Even when both say “thyroid hormone,” they do not establish self-equivalent substitution, split-and-combine use or alternation." }, { "zh": "标签涉及与食物、矿物质补充剂、抗酸药和多种药物的吸收相关问题。家中有钙、铁、胃药、降脂药、抗凝药或多种慢病药时，应带完整药单请药师或开方团队逐项核对。", "en": "The label addresses absorption-related issues with food, mineral supplements, antacids and multiple medicines. With calcium, iron, stomach medicines, lipid medicines, anticoagulants or multiple chronic-care products at home, bring the complete medicine list for pharmacist or prescribing-team review." }, { "zh": "疲劳、心悸、体重或睡眠变化不能由网页直接归因并自行调药。开始、减量、补服、转换或任何异常症状都应依据现行标签、化验与专业团队的具体判断。", "en": "Fatigue, palpitations, weight or sleep changes cannot be attributed by a webpage and used to self-adjust. Starting, tapering, make-up use, conversion or any concerning symptom needs the current label, testing and specific professional judgement." } ], "source": { "id": "src_6b43994eb7ece0a2", "label": "FDA：SYNTHROID 2020 美国处方信息（NDA 021402）", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021402s034lbl.pdf", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "historical_public_record", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "direct_document", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "scope": "label_literacy_only_no_individual_dosing_or_substitution" }, "mechanismReading": { "title": { "zh": "左甲状腺素怎样起作用：它提供合成的 T4 激素", "en": "How levothyroxine works: it provides synthetic T4 hormone" }, "summary": { "zh": "FDA 标签将左甲状腺素描述为合成的 T4（四碘甲状腺原氨酸），其生理作用由甲状腺激素受体介导。机制帮助解释为何单位、产品身份和实验室随访不能随意替换；它不判断个人甲状腺状态、剂量或化验目标。", "en": "The FDA label describes levothyroxine as synthetic T4 (tetraiodothyronine), with physiologic action mediated through thyroid-hormone receptors. This helps explain why units, product identity and laboratory follow-up cannot be freely substituted; it does not determine an individual thyroid state, dose or test target." }, "checks": [ { "zh": "T4 机制不让 mcg 与 mg、不同强度、不同品牌或不同市场产品可自行换算。每一片的单位、产品和处方都必须作为完整信息核对。", "en": "A T4 mechanism does not make mcg and mg, different strengths, brands or market products self-convertible. Each tablet’s unit, product and prescription must be checked as complete information." }, { "zh": "机制不能解释所有疲劳、心悸、体重或睡眠变化，也不能成为自行加减药的依据。症状、化验、其他疾病和完整药单都需要由专业人员综合评估。", "en": "Mechanism cannot explain every fatigue, palpitation, weight or sleep change, nor justify self-adjustment. Symptoms, tests, other conditions and the complete medicine list need integrated professional assessment." }, { "zh": "食物、矿物质补充剂和其他药物可能影响实际吸收或评估；这类相互作用必须回到准确产品的现行标签和药师/开方团队，而不是从机制词汇自行排时间表。", "en": "Food, mineral supplements and other medicines may affect real absorption or assessment; these interactions must return to the current label for the exact product and a pharmacist/prescribing team, not a self-made schedule from mechanism terms." } ], "source": { "id": "src_6b43994eb7ece0a2", "label": "FDA：SYNTHROID 2020 美国处方信息（临床药理）", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021402s034lbl.pdf", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "historical_public_record", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "direct_document", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "scope": "mechanism_literacy_only_no_individual_dosing_or_substitution" }, "pharmacovigilance": { "status": "official_routes_only_no_live_alert_inference", "reviewedAt": "2026-08-22", "identity": { "brand": "Synthroid", "generic": "左甲状腺素", "dosageFormClass": "左甲状腺素钠口服片：25、50、75、88、100、112、125、137、150、175、200、300 mcg（本档案分别展示 12 个美国标签包装面板）" }, "labelSource": { "id": "src_9fe75faad23655ce", "label": "DailyMed（NLM）：SYNTHROID 左甲状腺素钠美国公开标签（AbbVie；2024-02 修订）", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "publication_status_unresolved", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "productRoutes": [ { "source": { "id": "src_9fe75faad23655ce", "label": "DailyMed（NLM）：SYNTHROID 左甲状腺素钠美国公开标签（AbbVie；2024-02 修订）", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "publication_status_unresolved", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "status": "product_level_public_record_verified", "authority": { "zh": "美国国家医学图书馆 DailyMed", "en": "U.S. National Library of Medicine DailyMed" }, "market": { "zh": "美国", "en": "United States" }, "recordType": { "zh": "公开药品标签", "en": "Public medicine label" }, "reviewedAt": "2026-08-20", "scope": { "zh": "已逐项核对本档案可公开访问的产品级来源入口。该核对不代表已完成所有国家或地区的实时警示检索，也不代表该药存在或不存在当前风险。", "en": "This dossier’s publicly accessible product-level route has been checked individually. It does not mean that real-time alerts in every country or region have been searched, or that the medicine has or does not have a current risk." } }, { "source": { "id": "src_6b43994eb7ece0a2", "label": "FDA：SYNTHROID 2020 美国标签档案（NDA 021402）", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021402s034lbl.pdf", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "historical_public_record", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "direct_document", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, "status": "product_level_public_record_verified", "authority": { "zh": "FDA", "en": "FDA" }, "market": { "zh": "美国", "en": "United States" }, "recordType": { "zh": "监管产品记录或标签档案", "en": "Regulatory product record or label archive" }, "reviewedAt": "2026-08-20", "scope": { "zh": "已逐项核对本档案可公开访问的产品级来源入口。该核对不代表已完成所有国家或地区的实时警示检索，也不代表该药存在或不存在当前风险。", "en": "This dossier’s publicly accessible product-level route has been checked individually. It does not mean that real-time alerts in every country or region have been searched, or that the medicine has or does not have a current risk." } } ], "recordRoute": { "status": "product_level_public_record_verified", "authority": { "zh": "美国国家医学图书馆 DailyMed", "en": "U.S. National Library of Medicine DailyMed" }, "market": { "zh": "美国", "en": "United States" }, "recordType": { "zh": "公开药品标签", "en": "Public medicine label" }, "reviewedAt": "2026-08-20", "scope": { "zh": "已逐项核对本档案可公开访问的产品级来源入口。该核对不代表已完成所有国家或地区的实时警示检索，也不代表该药存在或不存在当前风险。", "en": "This dossier’s publicly accessible product-level route has been checked individually. It does not mean that real-time alerts in every country or region have been searched, or that the medicine has or does not have a current risk." } }, "channels": [ { "id": "china-nmpa-drug-evaluation-centre", "authority": "NMPA 药品评价中心", "market": { "zh": "中国大陆", "en": "Mainland China" }, "title": { "zh": "药物警戒快讯与安全警示", "en": "Drug-vigilance bulletins and safety notices" }, "purpose": { "zh": "国家药监局药品评价中心发布的药物警戒快讯、安全警示及药品不良反应监测相关原始入口；具体产品仍须按批准文号、剂型、规格、持有人和公告日期逐项核对。", "en": "Primary NMPA Drug Evaluation Centre gateway for drug-vigilance bulletins, safety notices and adverse-reaction monitoring. Exact products still require checking approval number, dosage form, strength, authorisation holder and notice date item by item." }, "source": { "id": "src_05ff2860226564d4", "label": "国家药监局药品评价中心：药物警戒与安全警示入口", "url": "https://www.cdr-adr.org.cn/", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "official_safety_monitoring", "documentKind": "regulatory_safety_communication", "market": "CN", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-22", "reviewedAt": "2026-08-22" } }, { "id": "fda-drug-safety-communications", "authority": "FDA", "market": { "zh": "美国", "en": "United States" }, "title": { "zh": "药物安全通讯", "en": "Drug Safety Communications" }, "purpose": { "zh": "监管机构就重要新安全问题、标签变化或风险沟通发布的原始页面。", "en": "Primary FDA pages for important new safety issues, labelling changes and risk communications." }, "source": { "id": "src_9177df9e1825aa72", "label": "FDA：Drug Safety Communications", "url": "https://www.fda.gov/drugs/drug-safety-and-availability/drug-safety-communications", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "official_safety_monitoring", "documentKind": "regulatory_safety_communication", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-22", "reviewedAt": "2026-08-22" } }, { "id": "fda-medwatch", "authority": "FDA MedWatch", "market": { "zh": "美国", "en": "United States" }, "title": { "zh": "安全信息与严重问题报告", "en": "Safety information and serious-problem reporting" }, "purpose": { "zh": "美国 MedWatch 的安全信息和报告入口；报告不等同于已证实因果关系。", "en": "U.S. MedWatch safety-information and reporting gateway; a report does not itself establish causality." }, "source": { "id": "src_e4739cd55d27ab51", "label": "FDA：MedWatch 药品安全信息与不良事件报告计划", "url": "https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "official_safety_monitoring", "documentKind": "adverse_event_reporting", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-22", "reviewedAt": "2026-08-22" } }, { "id": "ema-pharmacovigilance", "authority": "EMA", "market": { "zh": "欧盟/欧洲经济区", "en": "European Union / European Economic Area" }, "title": { "zh": "药物警戒概览与 EudraVigilance", "en": "Pharmacovigilance overview and EudraVigilance" }, "purpose": { "zh": "欧盟药物警戒、疑似不良反应报告和 PRAC 安全评估的官方入口。", "en": "Official EU gateway for pharmacovigilance, suspected adverse-reaction reports and PRAC safety assessment." }, "source": { "id": "src_2ad42a3deae747d1", "label": "EMA：Pharmacovigilance overview", "url": "https://www.ema.europa.eu/en/human-regulatory-overview/pharmacovigilance-overview", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "official_safety_monitoring", "documentKind": "regulatory_safety_communication", "market": "EU", "accessStatus": "public_access_confirmed", "accessMode": "javascript_or_cookie_controls", "accessVerifiedAt": "2026-08-22", "reviewedAt": "2026-08-22" } }, { "id": "mhra-drug-safety-update", "authority": "MHRA", "market": { "zh": "英国", "en": "United Kingdom" }, "title": { "zh": "Drug Safety Update", "en": "Drug Safety Update" }, "purpose": { "zh": "英国 MHRA 面向专业人士和公众的药品安全更新原始发布页。", "en": "Primary UK MHRA medicine-safety updates for professionals and the public." }, "source": { "id": "src_23fdbe67abeafc63", "label": "MHRA：Drug Safety Update", "url": "https://www.gov.uk/drug-safety-update", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "official_safety_monitoring", "documentKind": "regulatory_safety_communication", "market": "UK", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-22", "reviewedAt": "2026-08-22" } }, { "id": "pmda-drug-safety", "authority": "PMDA", "market": { "zh": "日本", "en": "Japan" }, "title": { "zh": "药品安全信息", "en": "Medicine safety information" }, "purpose": { "zh": "日本 PMDA 药品安全信息的英文官方入口；具体产品仍应以日文产品页和现行文件复核。", "en": "PMDA’s English official safety gateway; exact products still require checking against the Japanese product page and current documents." }, "source": { "id": "src_06d6be2880f12024", "label": "PMDA：Safety Information Regarding Drugs", "url": "https://www.pmda.go.jp/english/safety/info-services/drugs/0001.html", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "official_safety_monitoring", "documentKind": "regulatory_safety_communication", "market": "JP", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-22", "reviewedAt": "2026-08-22" } }, { "id": "mfds-drug-safety-letters", "authority": "MFDS", "market": { "zh": "韩国", "en": "Republic of Korea" }, "title": { "zh": "药品安全性书信", "en": "Medicine safety letters" }, "purpose": { "zh": "韩国 MFDS 发布的药品安全性书信原始索引。原文为韩文，须按涉及产品、剂型、市场和日期逐项阅读；它不自动适用于其他市场，也不构成对个人情况的结论。", "en": "MFDS’s primary index for medicine safety letters in the Republic of Korea. The original notices are in Korean and must be read against the named product, dosage form, market and date; they do not automatically apply in another market or decide an individual case." }, "source": { "id": "src_2d7f5018cd05eff4", "label": "MFDS：药品安全性书信（韩文原始资料）", "url": "https://www.mfds.go.kr/brd/m_545/list.do", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "official_safety_monitoring", "documentKind": "regulatory_safety_communication", "market": "KR", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-22", "reviewedAt": "2026-08-22" } }, { "id": "hsa-adverse-events", "authority": "HSA", "market": { "zh": "新加坡", "en": "Singapore" }, "title": { "zh": "不良反应报告与药物安全信息", "en": "Adverse-event reporting and medicine-safety information" }, "purpose": { "zh": "新加坡 HSA 面向公众的疑似不良反应报告、药物安全信息与本地监管入口；一份报告不等同于个体因果关系，具体产品仍须按新加坡注册状态、剂型、规格、日期和现行产品资料逐项核对。", "en": "HSA’s public Singapore gateway for suspected adverse-event reporting and medicine-safety information. A report does not itself establish individual causality; exact products still require checking Singapore registration status, dosage form, strength, date and current product information." }, "source": { "id": "src_9240397d5a8574c1", "label": "HSA：Report adverse events", "url": "https://www.hsa.gov.sg/adverse-events/", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "official_safety_monitoring", "documentKind": "adverse_event_reporting", "market": "SG", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-22", "reviewedAt": "2026-08-22" } }, { "id": "health-canada-medeffect-advisories", "authority": "Health Canada", "market": { "zh": "加拿大", "en": "Canada" }, "title": { "zh": "MedEffect 加拿大：建议、警告与召回", "en": "MedEffect Canada: advisories, warnings and recalls" }, "purpose": { "zh": "加拿大政府 Health Canada 的 MedEffect 公开入口，汇集药品及健康产品的建议、警告、召回、报告与安全信息；具体产品仍须按市场、剂型、规格、公告日期和批号逐项核对。", "en": "Health Canada’s public MedEffect gateway for medicine and health-product advisories, warnings, recalls, reporting and safety information. Exact products still require checking market, dosage form, strength, notice date and lot item by item." }, "source": { "id": "src_212ec921fa6634ad", "label": "Health Canada：MedEffect Canada 建议、警告与召回", "url": "https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/advisories-warnings-recalls.html", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "official_safety_monitoring", "documentKind": "regulatory_safety_communication", "market": "CA", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-22", "reviewedAt": "2026-08-22" } }, { "id": "tga-safety-alerts", "authority": "TGA", "market": { "zh": "澳大利亚", "en": "Australia" }, "title": { "zh": "药品安全警示", "en": "Medicine safety alerts" }, "purpose": { "zh": "澳大利亚 TGA 的药品安全警示、建议和监测信息原始发布页。", "en": "Primary Australian TGA safety alerts, advisories and monitoring information for therapeutic products." }, "source": { "id": "src_ffe6142814f88fac", "label": "TGA：Safety alerts", "url": "https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "official_safety_monitoring", "documentKind": "regulatory_safety_communication", "market": "AU", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-22", "reviewedAt": "2026-08-22" } }, { "id": "swissmedic-pharmacovigilance", "authority": "Swissmedic", "market": { "zh": "瑞士", "en": "Switzerland" }, "title": { "zh": "药物警戒与不良反应报告", "en": "Pharmacovigilance and suspected adverse-reaction reporting" }, "purpose": { "zh": "瑞士 Swissmedic 的药物警戒、信号评估和疑似不良反应官方入口；报告或信号本身不等同于对个体因果关系的确认。", "en": "Official Swissmedic gateway for pharmacovigilance, signal assessment and suspected adverse-reaction reporting; a report or signal does not itself confirm individual causality." }, "source": { "id": "src_c854f813ce2671df", "label": "Swissmedic：Pharmacovigilance", "url": "https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/market-surveillance/pharmacovigilance.html", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "official_safety_monitoring", "documentKind": "adverse_event_reporting", "market": "CH", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-22", "reviewedAt": "2026-08-22" } }, { "id": "medsafe-safety-communications", "authority": "Medsafe", "market": { "zh": "新西兰", "en": "New Zealand" }, "title": { "zh": "药品安全通讯", "en": "Medicine safety communications" }, "purpose": { "zh": "新西兰 Medsafe 面向公众和专业人士的药品安全通讯与归档入口；旧公告可能已被现行产品资料更新。", "en": "New Zealand Medsafe gateway for public and professional medicine safety communications and archives; older notices may have been superseded by current product information." }, "source": { "id": "src_3510c1a523ec9769", "label": "Medsafe：Safety Communications", "url": "https://www.medsafe.govt.nz/safety/SafetyCommunications.asp", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "official_safety_monitoring", "documentKind": "regulatory_safety_communication", "market": "NZ", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-22", "reviewedAt": "2026-08-22" } }, { "id": "sahpra-safety-information", "authority": "SAHPRA", "market": { "zh": "南非", "en": "South Africa" }, "title": { "zh": "药物安全信息、警示与药物警戒", "en": "Medicine safety information, alerts and pharmacovigilance" }, "purpose": { "zh": "南非 SAHPRA 面向公众和专业人士的药物安全信息、警示与药物警戒入口；官方警示不等同于产品在所有情形下不安全，具体产品仍须按南非注册状态、剂型、规格、公告日期与现行资料逐项核对。", "en": "SAHPRA’s safety-information, alerts and pharmacovigilance gateway for the public and professionals in South Africa. An official alert does not itself mean a product is unsafe in every circumstance; exact products still require checking South African registration status, dosage form, strength, notice date and current product information." }, "source": { "id": "src_25b0aaefee742163", "label": "SAHPRA：Safety Information Updates / Pharmacovigilance", "url": "https://www.sahpra.org.za/safety-information-and-updates/", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "official_safety_monitoring", "documentKind": "regulatory_safety_communication", "market": "ZA", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-22", "reviewedAt": "2026-08-22" } }, { "id": "who-medicine-safety-alerts", "authority": "WHO", "market": { "zh": "全球", "en": "Global" }, "title": { "zh": "药品与疫苗安全警示档案", "en": "Medicine and vaccine safety-alert archive" }, "purpose": { "zh": "WHO 的跨市场安全警示档案；每条历史警示必须按公告日期、涉及产品和市场单独阅读。", "en": "WHO’s cross-market safety-alert archive; every historical notice must be read against its date, named product and market." }, "source": { "id": "src_9a7dc56ec34c7e1a", "label": "WHO：Safety alerts for medicines and vaccines", "url": "https://www.who.int/teams/regulation-prequalification/regulation-and-safety/pharmacovigilance/safety-alerts", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "official_safety_monitoring", "documentKind": "regulatory_safety_communication", "market": "GLOBAL", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-22", "reviewedAt": "2026-08-22" } }, { "id": "anvisa-pharmacovigilance", "authority": "Anvisa", "market": { "zh": "巴西", "en": "Brazil" }, "title": { "zh": "药物警戒、警示与 VigiMed", "en": "Pharmacovigilance, alerts and VigiMed" }, "purpose": { "zh": "巴西 Anvisa 的药物警戒原始入口，涵盖警示、药物警戒公告、风险沟通和 VigiMed 报告路径；具体产品仍须按巴西批准状态、剂型、规格和公告日期逐项核对。", "en": "Anvisa’s primary Brazilian pharmacovigilance gateway for alerts, bulletins, risk communication and VigiMed reporting. Exact products still require checking Brazilian authorisation status, dosage form, strength and notice date item by item." }, "source": { "id": "src_5de362c12580111d", "label": "Anvisa：Farmacovigilância（药物警戒、警示与 VigiMed）", "url": "https://www.gov.br/anvisa/pt-br/assuntos/fiscalizacao-e-monitoramento/farmacovigilancia", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "official_safety_monitoring", "documentKind": "regulatory_safety_communication", "market": "BR", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-22", "reviewedAt": "2026-08-22" } } ], "notices": [], "boundary": { "zh": "本卡将逐药产品级来源与 15 个市场级官方警戒入口放在同一处核验；它不表示已完成该药在所有国家或地区的实时警示检索，也不表示该药存在新的安全警示、召回或风险结论。请先以品牌名、通用名、剂型、规格、所在市场和公告日期逐项匹配；不要仅因看到标题自行停药、换药、加量或减量。", "en": "This card brings together the medicine-specific product route and 15 market-level official vigilance gateways. It does not mean real-time alerts for this medicine have been searched in every country or region, or that the medicine has a new alert, recall or risk conclusion. Match brand, generic name, dosage form, strength, market and notice date item by item; do not self-stop, switch, increase or reduce use from a headline." }, "scope": "official_routes_only_no_live_alert_inference" }, "archive": { "summary": "美国 DailyMed 的 SYNTHROID（levothyroxine sodium）2024-02 公开标签列示 12 种每片微克（mcg）标示量。本页将每种强度与准确 NDC、包装面板及来源分别对应；“mcg／mg”是产品身份单位，不是个人该吃几片、能否对半、加减、补服、换药或换算的答案。", "history": "甲状腺激素产品的具体品牌、强度、剂型、包装、市场和现行标签需逐项核验。相同通用名、相近数字或都写“甲状腺素”不能证明可自行替代、交替、叠加或按毫克数换算；历史资料不构成个人用药、剂量、替代或购买建议。", "sourceDocuments": [ { "id": "src_9fe75faad23655ce", "label": "DailyMed（NLM）：SYNTHROID 左甲状腺素钠美国公开标签（AbbVie；2024-02 修订）", "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "publication_status_unresolved", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "public_web_page", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, { "id": "src_6b43994eb7ece0a2", "label": "FDA：SYNTHROID 2020 美国标签档案（NDA 021402）", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021402s034lbl.pdf", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "historical_public_record", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "direct_document", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" }, { "id": "src_5ed30b676fbb9773", "label": "FDA Drugs@FDA 官方检索入口", "url": "https://www.accessdata.fda.gov/scripts/cder/daf/", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "official_lookup_entry", "documentKind": "regulatory_lookup", "market": "US", "accessStatus": "public_access_requires_interaction", "accessMode": "interactive_lookup", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" } ], "applicationNumber": "NDA 021402", "approvalTimeline": [ { "date": "2002", "title": { "zh": "FDA 标签所列美国初始批准年份", "en": "Initial U.S. approval year listed in the FDA label" }, "detail": { "zh": "本页链接的 FDA 标签档案列示 Initial U.S. Approval: 2002。该历史定位不等同于当前批准、可得性、持有人或其他市场状态。", "en": "The FDA label archive linked here lists Initial U.S. Approval: 2002. This historical locator is not a conclusion about current approval, availability, holder or another market." }, "source": { "id": "src_6b43994eb7ece0a2", "label": "FDA: SYNTHROID label archive", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021402s034lbl.pdf", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "historical_public_record", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "direct_document", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" } }, { "date": "2020", "title": { "zh": "FDA 标签档案版本", "en": "FDA label archive version" }, "detail": { "zh": "本页链接 2020 的 FDA 标签档案作为可复核阅读入口。现行标签、规格、适应症和安全信息必须另行以目标市场当前文件核对。", "en": "This page links the 2020 FDA label archive as a traceable reading entry point. Current labeling, strength, indication and safety information require separate verification against the target market’s current document." }, "source": { "id": "src_6b43994eb7ece0a2", "label": "FDA: SYNTHROID label archive", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021402s034lbl.pdf", "audience": "public", "reviewStatus": "approved", "publish": true, "documentStatus": "historical_public_record", "documentKind": "product_label", "market": "US", "accessStatus": "public_access_confirmed", "accessMode": "direct_document", "accessVerifiedAt": "2026-08-20", "reviewedAt": "2026-08-20" } } ], "marketStatus": [ { "market": { "zh": "美国", "en": "United States" }, "status": { "zh": "已链接公开标签档案", "en": "Public label archive linked" }, "detail": { "zh": "仅对应本页所列 FDA 文件。", "en": "Only the FDA document listed on this page is linked." } }, { "market": { "zh": "中国大陆、欧盟、日本", "en": "Mainland China, EU, Japan" }, "status": { "zh": "待逐项建立市场记录", "en": "Market record not established" }, "detail": { "zh": "不从美国标签档案推定当地批准、持有人、规格、供应或可售资格。", "en": "No local approval, holder, strength, supply or sale-eligibility conclusion is inferred from the U.S. label archive." } } ], "frequentlyAskedQuestions": [ { "question": { "zh": "标签档案能代表现在的产品信息吗？", "en": "Does a label archive represent current product information?" }, "answer": { "zh": "不能自动代表。档案用于定位来源；需要以目标市场的现行官方标签逐项复核。", "en": "Not automatically. The archive locates a source; each point needs verification against the target market’s current official label." } }, { "question": { "zh": "为什么这里不展示价格或原研/仿制结论？", "en": "Why are price and originator/generic conclusions not shown?" }, "answer": { "zh": "这些结论需要产品、剂型、规格、包装、市场、日期和原始记录分别齐全并经人工审核；单一标签文件不足以支持。", "en": "Those conclusions require separately complete and human-reviewed product, dosage-form, strength, pack, market, date and primary-record fields; one label file is insufficient." } } ], "relatedMedicineChecks": [], "relatedArticleSlugs": [ "medicine-label-for-everyday-questions", "how-to-read-a-drug-label", "regulatory-sources-first" ] }, "canonicalUrls": { "zh": "https://origindrug.com/drugs/synthroid/", "en": "https://origindrug.com/en/drugs/synthroid/" }, "limitations": [ "No originator, generic, interchangeability, availability, price, holder, strength or sale-eligibility conclusion is inferred beyond the linked source documents.", "Target-market current labels and official records must be checked separately." ] }